Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,534 | 574 | 91.9% |
| Consulting Fee | $1,095 | 1 | 8.0% |
| Education | $14.37 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $1,998 | 39 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,673 | 83 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,349 | 64 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,182 | 82 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $741.09 | 31 | $0 (2024) |
| Amgen Inc. | $703.12 | 34 | $0 (2024) |
| CSL Behring | $673.76 | 30 | $0 (2024) |
| PFIZER INC. | $623.22 | 23 | $0 (2024) |
| Shire North American Group Inc | $538.53 | 31 | $0 (2019) |
| Genentech USA, Inc. | $436.22 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,893 | 81 | GlaxoSmithKline, LLC. ($254.39) |
| 2023 | $1,692 | 78 | Amgen Inc. ($232.80) |
| 2022 | $2,461 | 66 | GENZYME CORPORATION ($1,230) |
| 2021 | $1,135 | 53 | GlaxoSmithKline, LLC. ($226.54) |
| 2020 | $811.63 | 35 | AstraZeneca Pharmaceuticals LP ($112.59) |
| 2019 | $2,145 | 103 | GlaxoSmithKline, LLC. ($253.24) |
| 2018 | $2,148 | 89 | GlaxoSmithKline, LLC. ($363.46) |
| 2017 | $1,357 | 72 | AstraZeneca Pharmaceuticals LP ($250.51) |
All Payment Transactions
577 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Immunology | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.21 | General |
| Category: Immunology | ||||||
| 12/03/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/21/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $30.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.31 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.48 | General |
| Category: Immunology | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Immunology | ||||||
| 10/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: Immunology | ||||||
| 09/30/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: Inflammation | ||||||
| 09/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $32.90 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $35.89 | General |
| Category: VACCINES | ||||||
| 09/04/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Immunology | ||||||
| 08/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 547 | 6,519 | $257,034 | $164,256 |
| 2022 | 12 | 458 | 6,125 | $234,230 | $148,880 |
| 2021 | 11 | 299 | 5,351 | $219,096 | $144,145 |
| 2020 | 9 | 294 | 6,737 | $272,745 | $180,448 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 14 | 3,180 | $147,780 | $96,485 | 65.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 308 | $44,660 | $32,905 | 73.7% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 29 | 1,823 | $14,584 | $6,724 | 46.1% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 15 | 300 | $6,020 | $4,244 | 70.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $7,700 | $4,099 | 53.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 53 | 99 | $4,950 | $4,014 | 81.1% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 14 | 15 | $3,750 | $2,660 | 70.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 34 | 211 | $6,330 | $2,603 | 41.1% |
| 92567 | Test to assess middle ear function | Office | 2023 | 84 | 156 | $4,680 | $2,240 | 47.9% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 32 | 55 | $4,125 | $1,942 | 47.1% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 49 | 101 | $3,030 | $1,791 | 59.1% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 22 | 160 | $3,840 | $1,706 | 44.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 27 | 45 | $2,925 | $1,070 | 36.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 12 | 12 | $960.00 | $863.16 | 89.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $560.00 | $478.80 | 85.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 11 | 12 | $1,140 | $431.64 | 37.9% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 17 | 2,895 | $133,170 | $86,720 | 65.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 105 | 318 | $46,110 | $34,454 | 74.7% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 31 | 2,027 | $16,216 | $7,378 | 45.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 43 | 88 | $4,400 | $3,600 | 81.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $7,425 | $3,591 | 48.4% |
| 92567 | Test to assess middle ear function | Office | 2022 | 80 | 224 | $6,720 | $3,316 | 49.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 33 | 203 | $6,090 | $2,553 | 41.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 13 | $2,600 | $2,085 | 80.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 37 | 75 | $4,875 | $1,832 | 37.6% |
About Dr. Lananh Do, MD
Dr. Lananh Do, MD is a Allergy healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235247966.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lananh Do, MD has received a total of $13,643 in payments from pharmaceutical and medical device companies, with $1,893 received in 2024. These payments were reported across 577 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($12,534).
As a Medicare-enrolled provider, Do has provided services to 1,598 Medicare beneficiaries, totaling 24,732 services with total Medicare billing of $637,728. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Allergy
- Other Specialties Allergy & Immunology
- Location Los Angeles, CA
- Active Since 08/25/2006
- Last Updated 02/05/2020
- Taxonomy Code 207KA0200X
- Entity Type Individual
- NPI Number 1235247966
Products in Payments
- DUPIXENT (Biological) $2,664
- NUCALA (Biological) $827.05
- TEZSPIRE (Biological) $800.79
- CUVITRU (Biological) $522.03
- XOLAIR (Biological) $458.31
- SYMBICORT (Drug) $456.48
- Hizentra (Biological) $443.45
- Xolair (Biological) $436.22
- DUPIXENT DUPILUMAB INJECTION (Biological) $367.36
- TRELEGY ELLIPTA (Drug) $348.03
- Xhance (Drug) $347.43
- BREO (Drug) $316.39
- Odactra (Drug) $276.97
- CUTAQUIG (Biological) $274.84
- XOLAIR (Drug) $267.51
- CINRYZE (Drug) $260.57
- FASENRA (Biological) $243.28
- SPIRIVA RESPIMAT (Drug) $233.78
- Haegarda (Biological) $208.49
- EUCRISA (Drug) $207.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy Doctors in Los Angeles
Dr. Ricardo Tan, Md, MD
Allergy — Payments: $80,434
Dr. Robert Eitches
Allergy — Payments: $14,766
Dr. Maxine Baum, M.d, M.D
Allergy — Payments: $12,329
Bruce Goldberg, Md, MD
Allergy — Payments: $2,186
Michael Kaplan, Md, MD
Allergy — Payments: $1,810
Anne Staveren, Md, MD
Allergy — Payments: $1,384